MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks

J&J Vision closes TearScience buyout

September 6, 2017 By Brad Perriello Leave a Comment

Johnson & Johnson‘s (NYSE:JNJ) Vision business said today that it closed its acquisition of ophthalmological medical device maker TearScience for an undisclosed amount. Resarch Triangle Park, N.C.-based TearScience produces devices focused on treating meibomian gland dysfunction, a leading underlying cause of dry eye disease, Johnson & Johnson said. The company won FDA clearance for its office-based treatment […]

Filed Under: Mergers & Acquisitions, Optical/Ophthalmic, Wall Street Beat Tagged With: Johnson and Johnson, TearScience

J&J Vision to acquire TearScience

August 7, 2017 By Fink Densford Leave a Comment

Johnson & Johnson‘s (NYSE:JNJ) Vision business said last week that it inked a deal to acquire ophthalmological medical device maker TearScience for an undisclosed amount. Resarch Triangle Park, N.C.-based TearScience produces devices focused on treating meibomian gland dysfunction, a leading underlying cause of dry eye disease, Johnson & Johnson said. TearScience has won FDA clearance […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Optical/Ophthalmic Tagged With: Johnson and Johnson, TearScience

Boston Scientific taps ex-Covidien CFO Dockendorff, Hologic CEO MacMillan for board | Personnel Moves

March 4, 2015 By Brad Perriello Leave a Comment

Boston Scientific taps ex-Covidien CEO Dockendorff, Hologic CEO MacMillan for board | Personnel Moves

Filed Under: News Well Tagged With: Alphabet (Google), Biolase, Biomet, Boston Scientific, Breg Inc., Covidien, HeartFlow, Hologic, Laurimed, Penumbra Inc., Personnel Moves, SynCardia, TearScience

Toshiba lands 510(k) for latest Aquilon CT scanner | Regulatory Roundup

February 1, 2012 By MassDevice staff Leave a Comment

Toshiba

Toshiba’s (TYO:6502) American medical products division won 510(k) clearance from the FDA for the latest iteration in its Aquilon line of CT scanners.

The Aquilon Prime is designed for healthcare facilities that need to perform a wide variety of advanced clinical examinations with reduced radiation exposure, according to a press release.

Filed Under: 510(k), News Well Tagged With: Avedro Inc., Bovie Medical Corp., CardioKinetix Inc., Charter Medical, Custom Spine, Regulatory Roundup, TearScience, Toshiba, Yolo Medical

Entegrion lands $43.7 million DOD deal | Funding Roundup

October 5, 2011 By MassDevice staff Leave a Comment

Entegrion

Entegrion landed a $43.7 million dollar contract with the Dept. of Defense for its Resusix proprietary dehydrated pathogen-inactivated human plasma.

Resusix holds promise as a substitute for fresh frozen plasma in certain situations. The Defense Dept. contract will fund Resusix’s development through Phase III clinical trials and biological license application.

Filed Under: Blood Management, Funding Roundup, News Well Tagged With: defensedepartment, Dept. of Health & Human Services (HHS), Entegrion Inc., Image Stream Medical Inc., NxThera Inc., TearScience

TearScience Secures $15 Million In Venture Debt Financing From Oxford Finance, LLC And Silicon Valley Bank

October 5, 2011 By MassDevice Leave a Comment

TearScience Secures $15 Million In Venture Debt Financing From Oxford Finance, LLC And Silicon Valley Bank

MorrisvilLe, N.C.,—October 3, 2011—TearScience, Inc., a privately-held medical device company, today announced a $15M venture debt financing deal with Oxford Finance LLC and Silicon Valley Bank. The financing supports TearScience’s commercialization efforts of its new, innovative solution for evaluating the eye’s natural tear film and treating evaporative dry eye disease.

Filed Under: Uncategorized Tagged With: Press Release, TearScience

Stryker announces new international group president | Personnel Moves

August 23, 2011 By MassDevice staff Leave a Comment

Stryker

Stryker Corp. (NYSE:SYK) named a new international group president to take over as Andrew Fox-Smith resigned from the position to pursue other career opportunities.

Ramesh Subrahmanian takes the role, effective September 1, after having most recently served as senior VP and president, Asia Pacific, for Merck & Co. (NYSE:MRK).

Filed Under: News Well Tagged With: Allergan, Devicor Medical Products, Electromed, Encision Inc., Navidea Biopharmaceuticals, Osprey Medical, Personnel Moves, Stryker, Tangent Medical Technologies Inc., TearScience, wrightmedical

FDA Final Rule: TearScience’s LipiFlow eyelid thermal pulsation downgraded to Class II

August 19, 2011 By MassDevice staff Leave a Comment

TearScience
FDA

The FDA released a final rule declaring thermal pulsation systems Class II devices, allowing them to bypass the more stringent premarket approval required for Class III devices, in response to a petition from TearScience Inc.

Morrisville, N.C.-based TearScience had petitioned the watchdog agency to classify its LipiFlow eyelid thermal pulsation device, used in treatment of evaporative dry eye, as a Class II device.

Filed Under: News Well Tagged With: TearScience

Tengion CEO Nichtberger resigns | MassDevice.com Personnel Moves

August 16, 2011 By MassDevice staff Leave a Comment

Tengion

Tengion Inc. (NSDQ:TNGN) chief scientific officer Timothy Bertram will handle CEO duties while the company searches for a new top executive following the June 30 resignation of Dr. Steven Nichtberger.

Filed Under: News Well Tagged With: Accellent Inc., Fujifilm, InSite Vision Inc., InspireMD, Personnel Moves, TearScience, Tengion Inc., Unilife Corp., Welch Allyn

Pain management: St. Jude lands first U.S. regulatory clearance for single-point neurostimulation lead delivery system

July 12, 2011 By MassDevice staff Leave a Comment

M and A Roundup

St. Jude Medical Inc. (NYSE:STJ) announced today that it won U.S. Food & Drug Administration clearance for its Epiducer lead delivery system for neurostimulation in treatment of chronic pain.

The clearance is the first of its kind for the U.S. The device allows physicians to place multiple neurostimulation leads and different types of leads through a single entry point, reducing the need for the multiple incisions typically required.

Filed Under: Neuromodulation/Neurostimulation, News Well, Pain Management Tagged With: Boston Scientific, Cardiac Sciences Corp., Remote Patient Monitoring, stjudemedical, TearScience, Vasomedical Inc.

Hospira lures Allergan president Michael Ball

March 8, 2011 By MassDevice staff Leave a Comment

MassDevice.com Personnel Moves

Hospira Inc. (NYSE:HSP) ended its search for a CEO by luring Allergan Inc. (NYSE:AGN) president Michael Ball to the corner office in San Diego.

Ball, 55, replaces Hospira founder Christopher Begley, who’s staying on as executive chairman.

Ball spent 16 years at Allergan, rising to president after stints leading its pharmaceuticals , global eye care and North American businesses.

Filed Under: News Well Tagged With: AdvaMed, Allergan, Boston Software Systems, CareFusion Corp., Hospira Inc., JenaValve, NeoStem, Nexus Dx, Ortho Kinematics Inc., Personnel Moves, RedBrick Health, Semprus BioSciences, TearScience, Xeridiem Medical

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS